What is NDC 10019-953?

10019-953 is the product NDC for Mesna, Mesna 100 mg/mL injection, solution, listed with the FDA by Baxter Healthcare Company. It has 2 package NDCs, shown above in 10- and 11-digit form.

Baxter Healthcare Company, NDC labeler code 10019. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Mesna?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Mesna NDC 10019-953 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)10019-953Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10019-0953Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
10019-953-01	10019095301	1 VIAL, MULTI-DOSE in 1 BOX (10019-953-01) / 10 mL in 1 VIAL, MULTI-DOSE (10019-953-62)Marketed from Dec 30, 1988
10019-953-02	10019095302	10 VIAL, MULTI-DOSE in 1 BOX (10019-953-02) / 10 mL in 1 VIAL, MULTI-DOSE (10019-953-62)Marketed from Dec 30, 1988

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mesna
Generic name (nonproprietary): mesna
Active ingredients: Mesna — 100 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Baxter Healthcare CompanyNDC labeler code 10019
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 019884
Marketing start: Dec 30, 1988
Listing expires: Dec 31, 2027
Identifiers: Product ID 10019-953_351aee07-c5c9-46b3-9d0e-c3859796abacSPL ID 351aee07-c5c9-46b3-9d0e-c3859796abacSPL set ID fe1683ef-0569-411e-8188-0499884632adRxCUI 204870UNII NR7O1405Q9
Pharmacologic class: Cytoprotective Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N410019095301 followed by a unit qualifier and the quantity

Package 10019-0953-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 17, 2018.

Indications (excerpt from the label)

Mesna is indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. Limitation of Use: Mesna is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia. Mesna is a cytoprotective agent indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. ( 1 ) Limitation of Use: Mesna is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 10019-953

What is NDC 10019-953?: 10019-953 is the product NDC for Mesna, Mesna 100 mg/mL injection, solution, listed with the FDA by Baxter Healthcare Company. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Mesna.
What is the active ingredient?: Mesna.
Who is the labeler?: Baxter Healthcare Company, NDC labeler code 10019. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Mesna?: 7 other product NDCs are listed under this name. See all Mesna NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Mesna NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Mesna	Mesna 100 mg/mL	Injection, SolutionIntravenous	Eugia US LLC	55150-520	55150-0520-01
Mesna	Mesna 400 mg/1	Tablet, Film coatedOral	Ingenus Pharmaceuticals, LLC	50742-354	50742-0354-01
Mesnamesna injection	Mesna 100 mg/mL	SolutionIntravenous	Gland Pharma Limited	68083-161	68083-0161-0168083-0161-10
Mesna	Mesna 100 mg/mL	Injection, SolutionIntravenous	Sagent Pharmaceuticals	25021-201	25021-0201-1025021-0201-11
mesna	Mesna 100 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9260	00143-9260-01
Mesna	Mesna 100 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	63323-733	63323-0733-1063323-0733-11
Mesna	Mesna 100 mg/mL	Injection, SolutionIntravenous	Baxter Healthcare Company	10019-951	10019-0951-05

Other NDCs under NDA 019884

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 019884
Product	Strength	Form · route	Labeler	Product NDC
Mesnexmesna	Mesna 100 mg/mL	Injection, SolutionIntravenous	Baxter Healthcare Company	0338-1305
Mesnexmesna	Mesna 100 mg/mL	Injection, SolutionIntravenous	Baxter Healthcare Company	0338-1307
Mesna	Mesna 100 mg/mL	Injection, SolutionIntravenous	Baxter Healthcare Company	10019-951
Mesnexmesna	Mesna 100 mg/mL	Injection, SolutionIntravenous	Bamboo US Bidco LCC	83703-559